Aarti Drugs to Acquire 26% Stake in Renewable Energy Company

Published on 10/01/2025 at 09:42 - Modified on 10/01/2025 at 09:43

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Aarti Drugs Limited

Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	07/05	MT
Aarti Drugs Limited, Q4 2025 Earnings Call, May 07, 2025	07/05
Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	06/05	CI
Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees	06/05	RE
Aarti Drugs Receives Administrative Warning Letter From SEBI	07/03	RE
Aarti Drugs Says SEBI Issues Administrative Warning To Co's Compliance Officer, Company Secretary	06/03	RE
US FDA Removes Import Alert on Aarti Drugs Limited's API Manufacturing Facility	14/02	CI
Aarti Drugs Limited Receives an Order Refer with GST DRC-07 from the CGST & C.Ex. Authority	07/02	CI
Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine	03/02	RE
Aarti Drugs Limited, Q3 2025 Earnings Call, Jan 30, 2025	30/01
Pinnacle Life Science Pvt. Ltd announced that it expects to receive INR 250 million in funding from Aarti Drugs Limited	29/01	CI
Aarti Drugs Limited Receives Order in Form DRC-22 from Office of Joint Commissioner of State Tax, Investigation-B, Mumbai	28/01	CI
Aarti Drugs to Acquire 26% Stake in Renewable Energy Company	10/01	MT
Pro-Zeal Green Power Six Private Limited announced that it expects to receive INR 0.63 million in funding from Aarti Drugs Limited	09/01	CI
Aarti Drugs Restores Manufacturing Actitvity at Tarapur, India Unit	18/11	MT
Aarti Drugs Limited Announces Restoration of Manufacturing Process of Particular Product At T-150 Unit	16/11	CI
Aarti Drugs Limited, Q2 2025 Earnings Call, Oct 25, 2024	25/24/25
Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on August 26, 2024.	26/24/26	CI
Aarti Drugs Limited Announces Conduction of Inspection by United States Food and Drug Administration	25/24/25	CI
Aarti Drugs Limited's Equity Buyback announced on August 26, 2024 has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	19/24/19	CI
Aarti Drugs Gets Board Nod to Buy Back Shares of Up to INR598.5 Million	26/24/26	MT
Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	26/24/26	CI
Aarti Drugs Limited authorizes a Buyback Plan.	26/24/26	CI
Aarti Drugs Limited's Board intends to launch an Equity Buyback on August 26, 2024.	21/24/21	CI
Aarti Drugs Limited Receives Show Cause Notice from Central Goods and Service Tax & Central Excise	03/24/03	CI